Company Number: 14778479

Analysis Date: 2025-07-20 17:07 UTC

1. Credit Opinion: CONDITIONAL APPROVAL CELL SPOT 786 LTD is a newly incorporated micro-entity engaged in online retail (SIC 47910). With only one financial year filed, the company shows a small positive net asset position (£779) but negative net current assets (-£346), indicating short-term liquidity constraints. The absence of employees and minimal fixed and current assets suggest limited operational scale. The director and significant shareholder is Miss Shumaila Asif, who assumed control mid-2023, replacing Mr Asif Javed. Given the company's nascent stage, limited financial history, and marginal working capital, credit approval should be conditional on obtaining updated management accounts and evidence of improved liquidity before extending credit facilities.

2. Financial Strength: The balance sheet reflects very modest resources: fixed assets at £1,125 and current assets of £586, offset by current liabilities of £932. The net assets total £779, which is positive but minimal, indicating a fragile capital base. No long-term liabilities or provisions exist, which simplifies the risk profile but also shows lack of financial depth. The company meets micro-entity thresholds, reporting under simplified accounting standards. Overall, the financial strength is weak due to limited asset base and working capital deficit.

3. Cash Flow Assessment: Current liabilities exceed current assets by £346, implying a net current liability position. This could indicate cash flow pressure in meeting short-term obligations and supplier payments. The absence of employees suggests low operating overhead, but cash inflows from sales and receivables are likely minimal given the short trading history. No detailed cash flow statement is available, but the small scale and micro-entity status imply limited cash reserves. Monitoring cash conversion cycles and receivables collection will be critical.

4. Monitoring Points:

• Updated interim financials to track improvements in liquidity and net current assets.
• Sales growth metrics and receivables aging to assess cash inflow stability.
• Director conduct and governance, noting recent director changes and concentration of control with one individual.
• Timely filing of future accounts and confirmation statements to ensure compliance.
• Any material increases in liabilities or capital injections.